| Literature DB >> 22578154 |
Iris Plug1, Rasmus Hoffmann, Barbara Artnik, Matthias Bopp, Carme Borrell, Giuseppe Costa, Patrick Deboosere, Santi Esnaola, Ramune Kalediene, Mall Leinsalu, Olle Lundberg, Pekka Martikainen, Enrique Regidor, Jitka Rychtarikova, Björn Heine Strand, Bogdan Wojtyniak, Johan P Mackenbach.
Abstract
BACKGROUND: Previous studies have reported large socioeconomic inequalities in mortality from conditions amenable to medical intervention, but it is unclear whether these can be attributed to inequalities in access or quality of health care, or to confounding influences such as inequalities in background risk of diseases. We therefore studied whether inequalities in mortality from conditions amenable to medical intervention vary between countries in patterns which differ from those observed for other (non-amenable) causes of death. More specifically, we hypothesized that, as compared to non-amenable causes, inequalities in mortality from amenable causes are more strongly associated with inequalities in health care use and less strongly with inequalities in common risk factors for disease such as smoking.Entities:
Mesh:
Year: 2012 PMID: 22578154 PMCID: PMC3413570 DOI: 10.1186/1471-2458-12-346
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Descriptive information on databases included in the analyses
| | | | | | |
| Belgium | Longitudinal | 1991–1996 | 24861015 | 1997/2001 | 18481 |
| Switzerland | Longitudinal | 1990–2000 | 27910587 | NA | NA |
| | | | | | |
| Sweden | Longitudinal | 1991–2000 | 43042216 | 2000/2001 | 11484 |
| Finland | Longitudinal | 1990–2000 | 25874201 | 1994/’96/’98/’00/’02’04 | 20371 |
| Denmark | Longitudinal | 1996–2000 | 13926290 | 2000 | 16690 |
| Norway | Longitudinal | 1990–2000 | 19956767 | 2002 | 6827 |
| | | | | | |
| Italy (Turin) | Longitudinal | 1991–2001 | 4873109 | 1999/2000† | 118245 |
| Spain (Barcelona) | Longitudinal | 1992–2001 | 8151810 | | |
| Spain (Madrid region) | Longitudinal | 1996–1997 | 3663332 | 2001† | 20748 |
| Spain (Basque country) | CS* linked | 1996–2001 | 6098457 | | |
| | | | | | |
| Estonia | CS* unlinked | 1998–2002 | 3435255 | 2002/2004 | 4376 |
| Lithuania | CS* linked | 2000–2002 | 5156703 | 1994/’96/’98/’00/’02/’04 | 11647 |
| | | | | ||
| Slovenia | Longitudinal | 1991–2000 | 9647451 | 2002 | 1489 |
| Poland | CS* unlinked | 2001–2003 | 54883245 | NA | NA |
| Czech republic | CS* unlinked | 1999–2003 | 25761450 | 2002 | 2476 |
| Hungary | CS* unlinked | 1999–2002 | 21031348 | 2000/2003 | 10532 |
NA Not available.
*CS=Cross-sectional, †Survey data represent the whole of Italy and Spain.
Numbers of deaths, age standardized mortality rates, and relative risks comparing lower to higher educational level for total, amenable and non-amenable mortality, by country
| | | |||||||
|---|---|---|---|---|---|---|---|---|
| | ||||||||
| | | | | | | | | |
| Belgium | 283349 | 1101.04 | 879.33 | 1.35 (1.33–1.36) | 219916 | 1.35 (1.33–1.37) | 63433 | 1.35 (1.33–1.37) |
| Switzerland | 255275 | 928.42 | 822.37 | 1.35 (1.34–1.37) | 151351 | 1.34 (1.33–1.36) | 103924 | 1.37 (1.35–1.39) |
| | | | | | | | | |
| Sweden | 393038 | 910.59 | 711.21 | 1.30 (1.29–1.31) | 211683 | 1.23 (1.22–1.24) | 181355 | 1.39 (1.38–1.40) |
| Finland | 270232 | 1208.20 | 900.75 | 1.38 (1.36–1.39) | 138377 | 1.33 (1.32–1.35) | 131855 | 1.45 (1.43–1.47) |
| Denmark | 136064 | 1229.15 | 945.3 | 1.32 (1.31–1.34) | 88658 | 1.32 (1.30–1.33) | 47406 | 1.34 (1.31–1.37) |
| Norway | 213022 | 1131.82 | 870.68 | 1.35 (1.34–1.36) | 109988 | 1.30 (1.29–1.32) | 103034 | 1.40 (1.38–1.42) |
| | | | | | | | | |
| Italy (Turin) | 50621 | 966.18 | 844.96 | 1.27 (1.24–1.30) | 32995 | 1.29 (1.25–1.33) | 17626 | 1.24 (1.19–1.29) |
| Spain (Barcelona) | 77101 | 1012.27 | 949.97 | 1.23 (1.21–1.25 | 49540 | 1.26 (1.24–1.29) | 27561 | 1.19 (1.15–1.22) |
| Spain (Madrid region) | 22588 | 730.66 | 706.06 | 1.22 (1.17–1.26) | 14546 | 1.25 (1.19–1.30) | 8042 | 1.17 (1.11–1.25) |
| Spain (Basque country) | 41813 | 631.02 | 666.00 | 1.09 (1.06–1.12) | 27215 | 1.12 (1.08–1.16) | 14598 | 1.04 (1.00–1.09) |
| | | | | | | | | |
| Estonia | 60873 | 1914.96 | 1169.01 | 1.43 (1.40–1.45) | 27955 | 1.40 (1.36–1.43) | 32918 | 1.45 (1.42–1.49) |
| Lithuania | 78399 | 1883.58 | 939.51 | 1.67 (1.64–1.88) | 37613 | 1.70 (1.66–1.74) | 40786 | 1.66 (1.62–1.70) |
| | | | | | | | | |
| Slovenia | 101557 | 1242.52 | 1082.34 | 1.43 (1.41–1.45) | 57021 | 1.45(1.43–1.48) | 44536 | 1.41 (1.38–1.44) |
| Poland | 717743 | 1288.73 | 704.56 | 1.87 (1.86–1.88) | 397948 | 1.85 (1.84–1.87) | 319795 | 1.88 (1.86–1.89) |
| Czech republic | 344973 | 1188.16 | 690.26 | 1.92 (1.91–1.94) | 178032 | 1.85 (1.83–1.88) | 166941 | 2.01 (1.98–2.03) |
| Hungary | 368029 | 1548.94 | 869.52 | 1.93 (1.91–1.94) | 191651 | 1.86 (1.83–1.88) | 176378 | 2.00 (1.98–2.03) |
*ASMR=age standardized mortality rate per 100.000 person-years.
† Lower education is a combination of primary or no education and lower secondary education, higher education is a combination of upper secondary education and tertiary education.
‡ RR=relative risk adjusted for age and sex.
Figure 1International pattern of inequalities in amenable and non-amenable mortality.
Correlation between inequalities in amenable mortality and inequalities in mortality from all causes and from non-amenable causes
| | | |
| All infectious diseases | 0.832* | 0.858* |
| Tuberculosis (TB) | 0.812* | 0.708* |
| Pneumonia/influenza | 0.921* | 0.921* |
| Other infectious disease | 0.432 | 0.509* |
| | | |
| All amenable cancers | 0.595* | 0.789* |
| Cervical cancer | −0.410 | −0.344 |
| Testicular cancer | 0.587* | 0.726* |
| Colorectal cancer | 0.472 | 0.601* |
| Hodgkin’s disease and leukaemia | 0.357 | 0.553* |
| | | |
| All amenable cardiorespiratory conditions | 0.969* | 0.872* |
| Ischaemic heart disease | 0.907* | 0.822* |
| Cerebrovascular disease | 0.952* | 0.889* |
| Chronic rheumatic heart disease | 0.611* | 0.554* |
| Hypertension | 0.798* | 0.608* |
| Asthma | 0.731* | 0.588* |
| Other heart disease | 0.125 | 0.161 |
| | | |
| All amenable gastrointestinal conditions | 0.853* | 0.729* |
| Appendicitis, hernia, peptic ulcer | 0.873* | 0.766* |
| Cholecystitis and -lithiasis | 0.316 | 0.166 |
*Significant correlation, p < 0.05.
Analysis based on data in Table 2.
Educational inequalities in use of health care comparing low educational to high educational level
| | | | | | | | | | |
| Belgium | 1.14 (1.09–1.20) | 0.73 (0.69–0.77) | 0.95 (0.91–1.00) | 0.99 (0.90–1.11) | 0.82 (0.78–0.86) | 1.15 (1.07–1.24) | 0.69 (0.66–0.72) | 0.73 (0.66–0.79) | 0.55 (0.50–0.61) |
| Switzerland | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| | | | | | | | | | |
| Sweden | NA | NA | 0.83 (0.73–0.94) | NA | NA | NA | NA | NA | NA |
| Finland | NA | NA | 0.78 (0.73–0.84) | NA | NA | NA | 0.60 (0.53–0.68) | 0.71 (0.56–0.91) | NA |
| Denmark | 0.88 (0.80–0.97) | 0.64 (0.54–0.76) | 0.84 (0.76–0.92) | 1.06 (0.88–1.28) | 0.92 (0.84–1.02) | 1.08 (0.93–1.24) | 0.85 (0.77–0.94) | 0.88 (0.80–0.98) | NA |
| Norway | 1.00 (0.82–1.24) | 0.70 (0.56–0.87) | 0.96 (0.78–1.19) | 1.13 (0.89–1.44) | 1.20 (0.97–1.47) | 1.07 (0.86–1.32) | NA | NA | NA |
| | | | | | | | | | |
| Italy | 1.03 (0.98–1.08) | 0.72 (0.69–0.76) | 0.87 (0.83–0.90) | 1.05 (0.98–1.13) | 0.83 (0.81–0.87) | 1.21 (1.13–1.31) | 0.84 (0.82–0.87) | 0.82 (0.79–0.85) | 0.70 (0.68–0.73) |
| Spain | NA | NA | 0.91 (0.82–1.01) | 0.88 (0.75–1.02) | 0.90 (0.83–0.98) | NA | NA | NA | NA |
| | | | | | | | | | |
| Estonia | 0.87 (0.74–1.02) | 0.74 (0.63–0.86) | 0.73 (0.62–0.87) | 1.10 (0.92–1.33) | 1.09 (0.92–1.27) | NA | 0.83 (0.70–0.98) | 0.72 (0.50–1.02) | 0.55 (0.44–0.69) |
| Lithuania | NA | NA | 0.74 (0.67–0.82) | NA | NA | NA | 0.97 (0.88–1.07) | 0.69 (0.61–0.78) | NA |
| | | | | | | | | ||
| Slovenia | NA | NA | 0.79 (0.56–1.12) | NA | NA | NA | NA | NA | NA |
| Poland | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| Czech Republic | NA | NA | NA | 0.97 (0.78–1.12) | 0.66 (0.54–0.81) | 1.58 (1.23–2.03) | 0.79 (0.70–0.90) | 1.07 (0.94–1.22) | 0.62 (0.48–0.81) |
| Hungary | 0.80 (0.71–0.89) | 0.55 (0.49–0.61) | 0.65 (0.58–0.75) | 1.00 (0.89–1.13) | 0.65 (0.59–0.73) | 0.59 (0.55–0.65) | 0.67 (0.55–0.86) | NA | |
*Adjusted for age, sex and self rated health, **(OR CI95)=odd ratio with 95% confidence interval’ In the calculation of the odds ratio the highest educational level is the reference group.
For Switzerland and Poland no survey data were available.
Inequalities in smoking and overweight in European countries between low and high educational groups
| | | | | |
| Belgium | 1.51 (1.45–1.58) | 1.51 (1.45–1.57) | 1.72 (1.68–1.77) | 1.44 (1.33–1.56) |
| Switzerland | NA | NA | NA | NA |
| | | | | |
| Sweden | 1.26 (1.13–1.40) | 0.96 (0.87–1.05) | 1.33 (1.31–1.35) | 1.78 (1.72–1.84) |
| Finland | 1.29 (1.12–1.36) | 1.07 (1.02–1.13) | 1.78 (1.73–1.84) | 1.67 (1.61–1.74) |
| Denmark | 1.45 (1.35–1.56) | 1.25 (1.16–1.34) | 1.42 (1.38–1.46) | 1.32 (1.25–1.39) |
| Norway | 1.43 (1.25–1.64) | 0.95 (0.83–1.09) | 1.57 (1.53–1.63) | 1.76 (1.65–1.89) |
| | | | | |
| Italy | 1.08 (1.05–1.11) | 1.51 (1.45–1.57) | 1.21 (1.16–1.27) | 2.31 (1.63–3.47) |
| Spain | 1.21 (1.13–1.29) | NA | 1.43 (1.37–1.49) | 1.87 (1.42–2.47) |
| | | | | |
| Estonia | 1.27 (1.11–1.45) | 0.95 (0.83–1.08) | 1.64 (1.54–1.74) | 1.88 (1.70–2.07) |
| Lithuania | 1.48 (1.35–1.62) | 1.03 (0.95–1.08) | 2.21 (2.09–2.34) | 2.78 (2.53–3.07) |
| | | | | |
| Slovenia | 1.40 (1.09–1.81) | 1.11 (0.86–1.42) | 1.52 (1.47–1.58) | 2.41 (2.26–2.57) |
| Poland | NA | NA | NA | NA |
| Czech Republic | 1.86 (1.62–2.12) | 1.27 (1.12–1.14) | 2.41 (2.34–2.47) | 2.69 (2.52–2.87) |
| Hungary | 1.88 (1.72–2.05) | 1.21 (1.12–1.32) | 2.09 (2.04–2.14) | 2.27 (2.19–2.33) |
*Smoking= current regular smoking and occasional smoking, Overweight=body mass index > 25.
† OR (CI95)=odds ratio with 95% confidence interval adjusted for age and sex.
‡Smoking related death are chronic obstructive pulmonary disease and cancer of the buccal cavity, pharynx, oesophagus, larynx, trachea, bronchus, and lung.
∥Alcohol related deaths are accidental poisoning by alcohol and alcoholic psychosis, dependence, abuse, cardiomyopathy, cirrhosis of the liver and inflammation of the pancreas.
For Switzerland and Poland no survey data were available (NA).
Correlation between inequalities in amenable mortality, inequalities in use of health careand inequalities in behavioural risk factors
| Number of observations | 11 | 8 | 8 | 8 | 8 | 12 | 11 | 14 | 14 |
| Non amenable causes of death | −0.745* | −0.213 | −0.704 | −0.059 | 0.175 | 0.859* | 0.059 | 0.806* | 0.632* |
| All amenable infectious diseases | −0.762* | −0.010 | −0.530 | 0.297 | −0.095 | 0.637* | −0.209 | 0.603* | 0.659* |
| All amenable cancers | −0.334 | −0.443 | −0.752* | −0.071 | 0.604 | 0.705* | 0.203 | 0.578* | 0.613* |
| All amenable cardiorespiratory conditions | −0.731* | −0.096 | −0.613 | −0.289 | 0.214 | 0.916** | −0.022 | 0.851* | 0.463 |
| All amenable gastrointestinal conditions | 0.506 | −0.107 | −0.699 | −0.302 | 0.642 | 0.684* | 0.326 | 0.752* | 0.443 |
† Health care factors are included in the correlation analyses if these were available for at least half of the countries.
*Significant correlation, p < 0.05.
**Blood pressure screening.